License AgreementLicense Agreement • March 5th, 2024 • Tracon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMarch 5th, 2024 Company Industry JurisdictionThis License Agreement (this “Agreement”), effective as of November 17, 2023 (the “Effective Date”), is by and between Tracon Pharmaceuticals, Inc. (“Licensor”), and Inhibrx, Inc. (“Licensee”) (collectively, the “Parties,” or each, individually, a “Party”).